180 related articles for article (PubMed ID: 26775907)
1. Treatment Costs of Breast Cancer Among Younger Women Aged 19-44 Years Enrolled in Medicaid.
Ekwueme DU; Allaire BT; Guy GP; Arnold S; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):278-85. PubMed ID: 26775907
[TBL] [Abstract][Full Text] [Related]
2. Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years.
Allaire BT; Ekwueme DU; Guy GP; Li C; Tangka FK; Trivers KF; Sabatino SA; Rodriguez JL; Trogdon JG
Am J Prev Med; 2016 Feb; 50(2):270-7. PubMed ID: 26775906
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer in Young Women: Health State Utility Impacts by Race/Ethnicity.
Trogdon JG; Ekwueme DU; Chamiec-Case L; Guy GP
Am J Prev Med; 2016 Feb; 50(2):262-9. PubMed ID: 26775905
[TBL] [Abstract][Full Text] [Related]
4. Productivity Costs Associated With Breast Cancer Among Survivors Aged 18-44 Years.
Ekwueme DU; Trogdon JG; Khavjou OA; Guy GP
Am J Prev Med; 2016 Feb; 50(2):286-94. PubMed ID: 26775908
[TBL] [Abstract][Full Text] [Related]
5. Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis.
Trogdon JG; Ekwueme DU; Poehler D; Thomas CC; Reeder-Hayes K; Allaire BT
Breast Cancer Res Treat; 2017 Nov; 166(1):207-215. PubMed ID: 28702893
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program.
Khanna R; Madhavan SS; Bhanegaonkar A; Remick SC
J Womens Health (Larchmt); 2011 May; 20(5):739-47. PubMed ID: 21417935
[TBL] [Abstract][Full Text] [Related]
7. Health State Utility Impact of Breast Cancer in U.S. Women Aged 18-44 Years.
Brown DS; Trogdon JG; Ekwueme DU; Chamiec-Case L; Guy GP; Tangka FK; Li C; Trivers KF; Rodriguez JL
Am J Prev Med; 2016 Feb; 50(2):255-61. PubMed ID: 26775904
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Stage and Treatment Among Ohio Medicaid Beneficiaries With and Without Mental Illness.
Koroukian SM; Bakaki PM; Golchin N; Tyler CV; Owusu C; Loue S
J Oncol Pract; 2015 Jan; 11(1):e50-8. PubMed ID: 25466705
[TBL] [Abstract][Full Text] [Related]
9. Estimation of Breast Cancer Incident Cases and Medical Care Costs Attributable to Alcohol Consumption Among Insured Women Aged <45 Years in the U.S.
Ekwueme DU; Allaire BT; Parish WJ; Thomas CC; Poehler D; Guy GP; Aldridge AP; Lahoti SR; Fairley TL; Trogdon JG
Am J Prev Med; 2017 Sep; 53(3S1):S47-S54. PubMed ID: 28818245
[TBL] [Abstract][Full Text] [Related]
10. Association between medical home enrollment and health care utilization and costs among breast cancer patients in a state Medicaid program.
Kohler RE; Goyal RK; Lich KH; Domino ME; Wheeler SB
Cancer; 2015 Nov; 121(22):3975-81. PubMed ID: 26287506
[TBL] [Abstract][Full Text] [Related]
11. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
12. Cost of breast cancer treatment in Medicaid: implications for state programs providing coverage for low-income women.
Subramanian S; Trogdon J; Ekwueme DU; Gardner JG; Whitmire JT; Rao C
Med Care; 2011 Jan; 49(1):89-95. PubMed ID: 21079524
[TBL] [Abstract][Full Text] [Related]
13. Medical costs associated with metastatic breast cancer in younger, midlife, and older women.
Trogdon JG; Baggett CD; Gogate A; Reeder-Hayes KE; Rotter J; Zhou X; Ekwueme DU; Fairley TL; Wheeler SB
Breast Cancer Res Treat; 2020 Jun; 181(3):653-665. PubMed ID: 32346820
[TBL] [Abstract][Full Text] [Related]
14. Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks.
Hoerger TJ; Downs KE; Lakshmanan MC; Lindrooth RC; Plouffe L; Wendling B; West SL; Ohsfeldt RL
J Womens Health Gend Based Med; 1999 Oct; 8(8):1077-89. PubMed ID: 10565666
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity prevalence, healthcare utilization, and expenditures of Medicaid enrolled adults with autism spectrum disorders.
Vohra R; Madhavan S; Sambamoorthi U
Autism; 2017 Nov; 21(8):995-1009. PubMed ID: 27875247
[TBL] [Abstract][Full Text] [Related]
16. Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.
Gómez-Puerta JA; Barbhaiya M; Guan H; Feldman CH; Alarcón GS; Costenbader KH
Arthritis Rheumatol; 2015 Mar; 67(3):752-60. PubMed ID: 25590668
[TBL] [Abstract][Full Text] [Related]
17. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
Khanna R; Smith MJ
Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
[TBL] [Abstract][Full Text] [Related]
18. End-of-Life Medical Costs of Medicaid Cancer Patients.
Tangka FK; Subramanian S; Sabatino SA; Howard DH; Haber S; Hoover S; Richardson LC
Health Serv Res; 2015 Jun; 50(3):690-709. PubMed ID: 25424134
[TBL] [Abstract][Full Text] [Related]
19. State Medicaid expansion decisions and disparities in women's cancer screening.
Sabik LM; Tarazi WW; Bradley CJ
Am J Prev Med; 2015 Jan; 48(1):98-103. PubMed ID: 25441234
[TBL] [Abstract][Full Text] [Related]
20. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
Khanna R; Jariwala K; West-Strum D
J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
